Delivery Order SPE2DB22D1017-SPE2DB24FF0JB
Award Date
12/27/23
Potential Completion Date
12/28/23
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,035.05 for the supply of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,204.75 delivery order contract is for the supply of the pharmaceutical drug Glimepiride 1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 12, 2024. This award is not associated with a set-aside designation, indicating it was competed on an open market. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,832.48 for the supply of 4 mg Glimepiride tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award, valued at $14,004.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF1BT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glimepiride 4 mg tablets, a pharmaceutical product used to treat diabetes. The contract has a ceiling value of $5,031.97 and an ultimate completion date of January 11, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp, a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, specifically the drug Glimepiride 4 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $4,600.92, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,018.59, is for the delivery of 4,564,559,699 units of the pharmaceutical product GLIMEPIRIDE 4 MG TABLET 100S. This is a firm fixed-price delivery order with a completion date of May 10, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Glimepiride 4 mg tablet 100s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $2,849.69 and an Ultimate Completion Date of September 19, 2024. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award, with an ID of SPE2DB20D1051|SPE2DB24FD7FS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat diabetes. The award has a ceiling value of $2,778.33 and an ultimate completion date of March 7, 2024. This contract is a delivery order, with a firm fixed-price pricing type. The contract is not designated as a set-aside....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,974.55 firm-fixed-price delivery order is for the supply of 1,000 units of Glipizide ER 10 mg tablets. The award has a completion date of May 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...